Date: {{$ActivityAssignDate}}





























Dear {{$doctorName}},


Subject: {{$ActivityName}}



Tacrolimus ophthalmic is an immunosuppressive agent used to treat keratoconjunctivitis sicca (KCS), also known as dry eye. It can also be used for other immune mediated eye conditions such as chronic superficial keratitis (CSK), also inhibits the release of histamine from mast cells and impairs prostaglandin synthesis. Tacrolimus has shown to be effective in the treatment of immune-mediated diseases such as corneal graft rejection, ocular inflammation, ocular pemphigoid, and uveitis.
We invite you to participate in this survey and share relevant information about the diagnosis and management in real world practice in India.



We trust you and we are partners in promoting safe effective medical therapy. In that spirit we hope you will consent to participate in this study. If you do, please sign and return the enclosed reply along with your visiting card for accuracy of records



Yours truly,

Sandeep Sharma
Associate Vice President
Sun Pharma Laboratories Ltd
Mumbai

To, Mr. Sandeep Sharma,
Associate Vice President

Date: {{$ActivityAssignDate}}

Sun Pharma Laboratories Limited,
Sun House, Plot No. 201,B/1,
Western Express Highway,
Goregaon (E), Mumbai 400063


Subject: {{$ActivityName}}


In response to your letter dated 1st October ,2022 I agree to participate in the survey as outlined by you. I understand that:


  • You will provide me with the copy of a questionnaire ( softcopy )

  • Questionnaire would be used & the treatment would be prescribed as in my routine practice

  • The patient’s identity will not be disclosed in the DCF


My personal details are given below for accuracy of your records:
Name: {{$doctorName}}
Qualifications:
Speciality:
Postal Address:
Clinic or Hospital Telephone Number:
Residence Telephone Number:

Yours sincerely,

[Signature & Stamp]
{{$doctorName}}